Pradžia › Pneumokokinės infekcijos › Kalifornija
Pneumokokinės infekcijos klinikiniai tyrimai Kalifornija
5 tyrimai dėl Pneumokokinės infekcijos ieško dalyvių vietose Kalifornija.
Oficialus tyrimo tekstas (anglų kalba)
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
- Madera Family Medical Group ( Site 1004), Madera
Renkami dalyviai1 fazėLaukiami sveiki savanoriai
2 Months – 15 Months · Visoms lytims · Atnaujinta 2026-10-02 · NCT07300267A Study to Assess the Safety, Tolerability, and Immunogenicity of 3 Lots of a Multivalent Pneumococcal Conjugate Vaccine Administered to Adults
- Orange County Research Center, Lake Forest
- Diablo Clinical Research, LLC dba Flourish Research, Walnut Creek
Renkami dalyviai3 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 49 · Visoms lytims · Atnaujinta 2026-09-23 · NCT07794748A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
- Advanced Research Center, Inc., Anaheim
- San Gabriel Woman's Health, Arcadia
- Coast Clinical Research, LLC, Bellflower
- ir dar 5
Renkami dalyviai3 fazėLaukiami sveiki savanoriai
42 Days – 211 Days · Visoms lytims · Atnaujinta 2026-09-08 · NCT07629440Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents
- Apex Research Group, Fair Oaks
- Orange County Research Institute, Ontario
Renkami dalyviai3 fazėLaukiami sveiki savanoriai
15 Months – 17 Years · Visoms lytims · Atnaujinta 2026-08-31 · NCT07660198Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age
- Matrix Clinical Research - Huntington Park- Site Number : 8400029, Huntington Park
- Community Clinical Research- Site Number : 8400030, Los Angeles
- Matrix Clinical Research - Los Angeles- Site Number : 8400028, Los Angeles
Renkami dalyviai3 fazėLaukiami sveiki savanoriai
42 Days – 89 Days · Visoms lytims · Atnaujinta 2026-05-22 · NCT07348692Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.